Skip to main content

Table 1 Baseline Demographic and Clinical Characteristics*

From: Mobile health, exercise and metabolic risk: a randomized controlled trial

Characteristic Intervention (n =75) Active Control (n =74)
Demographics   
Age (years) 55.7 (10.1) 57.8 (8.7)
Sex (female) 55 (73.3%) 56 (75.7%)
Race (Caucasian) 74 (100%) 73 (100%)
Smoking status:   
 Current 3 (4.0%) 1 (1.4%)
 Former 31 (41.3%) 29 (39.2%)
History of Type 2 Diabetes 3 (4.0%) 4 (5.4%)
Antihypertensive Therapy 27 (36.0%) 33 (44.6%)
 Monotherapy 16 (59.3%) 21 (63.6%)
 Combination Therapy 11 (40.7%) 12 (36.3%)
 Angiotensin Converting   
 Enzyme Inhibitors 10 (37.0%) 20 (60.6%)
 Angiotensin Receptor Blockers 6 (22.2%) 10 (30.3%)
 Calcium Channel Blockers 4 (14.8%) 1 (3.0%)
 Diuretics 17 (63.0%) 15 (45.4%)
 Alpha Receptor Blockers 1 (3.7%) 0 (0%)
Average frequency of physical activity (in last 7 days), median (IQR) 2.5 (3.5) 3.0 (4.0)
pVO2max 30.5 (6.8) 31.2 (6.3)
  1. Abbreviations: IQR interquartile range, pVO 2max predicted maximal oxygen uptake (aerobic fitness).
  2. *Data are means (SD) or numbers (%) unless otherwise indicated. Percentages are calculated excluding missing values.
  3. Missing values: Intervention (n = 1) and Active Control (n = 1).
  4. Average of: (a) number days (in last 7) that at least 30 minutes of continuous physical activity was done and b) number of days (in last 7) participated in a specific exercise session.